tiprankstipranks
SELLAS Life Sciences Group (SLS)
NASDAQ:SLS
US Market

SELLAS Life Sciences Group (SLS) Income Statement

Compare
940 Followers

SELLAS Life Sciences Group Income Statement

Last quarter (Q3 2024), SELLAS Life Sciences Group's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q3, SELLAS Life Sciences Group's net income was $-7.11M. See SELLAS Life Sciences Group’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 0.00$ 1.00M$ 7.60M$ 1.90M$ 0.00
Gross Profit
$ 0.00$ 900.00K$ 7.40M$ 1.90M$ 0.00
Operating Expenses
$ 37.87M$ 42.85M$ 32.69M$ 18.88M$ 17.21M
Depreciation and Amortization
$ 37.87M$ 457.00K$ 1.27M$ 377.00K$ 17.21M
EBITDA
$ 529.00K$ -31.95M$ -19.66M$ -16.40M$ 668.00K
Operating Income
$ -37.87M$ -41.95M$ -25.29M$ -16.98M$ -20.04M
Other Income/Expenses
$ 529.00K$ 649.00K$ 4.36M$ 208.00K$ 668.00K
Pretax Income
$ -37.34M$ -41.30M$ -20.94M$ -16.77M$ -19.37M
Net Income
$ -37.34M$ -40.65M$ -20.70M$ -16.76M$ -19.29M
Per Share Metrics
$ ―$ ―$ ―$ ―$ ―
Basic EPS
$ -1.34$ -2.10$ -1.34$ -2.10$ -7.54
Diluted EPS
$ -1.34$ -2.10$ -1.34$ -2.10$ -7.54
Weighted Average Shares Outstanding
27.78M 19.40M 15.48M 7.98M 2.56M
Weighted Average Shares Outstanding (Diluted)
27.78M 19.40M 15.48M 7.98M 2.56M
Currency in USD

SELLAS Life Sciences Group Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis